← Back to Search

Implementation Strategies for Childhood Obesity Prevention

N/A

Recruiting

Led By Taren M Swindle, Ph.D.

Research Sponsored by University of Arkansas

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Timeline

Screening 3 weeks

Treatment Varies

Follow Up through study completion, an average of 2 years

Awards & highlights

Study Summary

This trial will compare a low-intensity implementation strategy to a more tailored, adaptive strategy that starts with low-intensity support and steps up to higher intensity support as needed.

Who is the study for?

This trial is for early care and education settings not currently using the WISE program, serving at least 15 children aged 3 to 5. They must be in certain regions of Arkansas or Louisiana, participate in specific food programs, and agree to join in activities and data collection.Check my eligibility

What is being tested?

The study tests 'Together, We Inspire Smart Eating' (WISE), aiming to improve kids' diets through hands-on experiences with fruits/veggies, educator role modeling, positive feeding practices, and a mascot. It compares low vs high-intensity strategies for better adoption.See study design

What are the potential side effects?

Since this intervention focuses on educational practices rather than medical treatments, traditional side effects are not applicable. However, there may be indirect impacts on children's behavior or preferences.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ through study completion, an average of 2 years

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~through study completion, an average of 2 years

This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Fidelity to WISE Evidence-Based Practices using the WISE fidelity observational measure

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Non-Responders Increasing to High IntensityExperimental Treatment2 Interventions

This group will include those not achieving desired levels of fidelity by the October assessment who will be randomized to have high intensity support added (low intensity + holistic individualized facilitation, tailored educational materials).

Group II: Non-Responders Continue Low IntensityActive Control1 Intervention

This group will include those not achieving desired levels of fidelity by the October assessment who will be randomized to continue receiving low intensity implementation support (i.e., formal commitments, local champions, implementation blueprint, reminder cutting boards, task-focused implementation).

Group III: Early Responders to Low IntensityActive Control1 Intervention

Early responders will include those with targeted levels of fidelity by the October assessment. They will continue to receive low intensity implementation support (i.e., formal commitments, local champions, implementation blueprint, reminder cutting boards, task-focused implementation).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Low Intensity

2005

N/A

~240

High Intensity

2017

N/A

~480

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Louisiana Tech UniversityUNKNOWN

University of ArkansasLead Sponsor

486 Previous Clinical Trials

148,503 Total Patients Enrolled

Taren M Swindle, Ph.D.Principal InvestigatorUniversity of Arkansas

Media Library

Low Intensity Clinical Trial Eligibility Overview. Trial Name: NCT05050539 — N/A

Nutrition and Cancer Research Study Groups: Non-Responders Continue Low Intensity, Non-Responders Increasing to High Intensity, Early Responders to Low Intensity

Nutrition and Cancer Clinical Trial 2023: Low Intensity Highlights & Side Effects. Trial Name: NCT05050539 — N/A

Low Intensity 2023 Treatment Timeline for Medical Study. Trial Name: NCT05050539 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this research endeavor actively searching for new participants?

"Affirmative. According to clinicaltrials.gov, this research endeavour is presently accepting participants; it was first posted on June 14th 2022 and most recently modified on July 8th 2022. The trial needs 1850 individuals from one medical centre to partake in the experiment."

Answered by AI

What is the scope of participants enrolled in this experiment?

"Indeed, the clinical trial is seeking out participants. It was posted on June 14th 2022 and recently revised on July 8th 2022. This research requires 1850 individuals to join from a single medical site."

Answered by AI

Recent research and studies

Implementation ScienceJournal

Obesity Prevention Practices in Early Care and Education Settings: An Adaptive Implementation Trial

Swindle, Taren, Julie M. Rutledge, James P. Selig, Jacob Painter, Dong Zhang, Janna Martin, Susan L. Johnson, et al.. 2022. “Obesity Prevention Practices in Early Care and Education Settings: An Adaptive Implementation Trial”. Implementation Science. Springer Science and Business Media LLC. doi:10.1186/s13012-021-01185-1.

clinicaltrials.govStudy

Adaptive Implementation to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings

2022. "Adaptive Implementation to Optimize Delivery of Obesity Prevention Practices in Early Care and Education Settings". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05050539.